Loading clinical trials...

Protocol for Optimizing Colonoscopy Preparation in Patients With Inflammatory Bowel Disease | Clinical Trials | Clareo Health

COMPLETEDNA

Protocol for Optimizing Colonoscopy Preparation in Patients With Inflammatory Bowel Disease

NCT04411017•Hospital Universitario La Paz

View on ClinicalTrials.gov

Summary

Clinical trial evaluating efficacy of bowel cleansing solutions in patients with Inflammatory Bowel Disease.

Detailed Description

Simple blind, randomized study evaluating efficacy of 1LPEG vs 2L PEG vs 2L sodium picosulfate in bowel cleansing of patients diagnosed of Inflammatory Bowel Disease undergoing diagnostic or follow-up routine colonoscopy.

Eligibility

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients between 18y and 90y
•Patients with a diagnosis of IBD undergoing follow-up or screening colonoscopy

Exclusion Criteria

•Patients \<18y or \>90y
•Pregnant Women
•Patients with a past history of inadequate bowel cleansing in a colonoscopy performed in the previous 12 months prior to initiation of study
•Patients with a history of bowel resection
•Patients undergoing therapeutic colonoscopy
•Patients unable to understand study protocol

Locations (1)

Hospital Universitario La Paz

Madrid, Madrd, Spain

Key Dates

Start Date

February 1, 2019

Primary Completion Date

June 30, 2021

Completion Date

July 20, 2021

Last Updated

July 23, 2021

Enrollment

100

ACTUAL participants

Conditions

Inflammatory Bowel Diseases

Interventions

Endoscopy

PROCEDURE

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

NCT06226883

Inflammatory Bowel DiseasesCrohn's Disease

View study

RECRUITING

Institutional Registry of Rare Diseases

NCT06573723

Rare DiseasesAmyloidosis+24 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 23, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Protocol for Optimizing Colonoscopy Preparation in Patients With Inflammatory Bowel Disease

Inclusion Criteria

Exclusion Criteria

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Institutional Registry of Rare Diseases

Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Clinnova-IBD, a Prospective Cohort of Patients With Inflammatory Bowel Disease (IBD)

Therapeutic Endpoint in Pediatric IBD Conditions